Study Finds Missing Protein Leads to Severe Neurological Condition

Rare Daily Staff

A new study identified the molecular causes of MEDS1, a rare and usually fatal genetic disease characterized by a small head, epilepsy, and diabetes.

Researchers at the Leibniz Institute on Aging at the Fritz Lipmann Institute published their findings in the journal Cellular and Molecular Life Sciences journal.

The study identified the underlying cause of MEDS1 as mutations in the IER3IP1 gene, which codes for a small protein in the endoplasmic reticulum (ER) membrane. This protein plays a crucial role in transporting molecules between the ER and the Golgi apparatus, an organelle within the cell that modifies, sorts, and packages proteins for transport.

The study shows, for the first time, that the absence of IER3IP1 or its mutation causes defective transport of certain proteins essential for nerve cell development and survival. Additionally, it found that the lack of IER3IP1 leads to an expansion of the ER membranes and increased lysosome activity. The scientists reported that the transport of certain sorting proteins is disrupted, which leads to defective secretion of ER proteins.

The findings expand the understanding of brain development. They open up new possibilities for research into similar mechanisms. The parallel to a related protein, YIPF5, is of particular interest, as it performs similar functions and whose mutation can cause a similar disease.

The study provides a starting point for potential therapeutic strategies against similar diseases. These include approaches such as the targeted correction of protein transport, modulation of the ER stress response, or gene therapy.

“The elucidation of these complex relationships was extremely challenging, especially from a technical perspective,” said research group leader Christoph Kaether.  “Advances in proteomics and cell surface analysis have enabled the team to measure the subtle differences in protein transport and the specific changes in cell structure caused by the absence of IER3IP1.